<DOC>
	<DOCNO>NCT00479778</DOCNO>
	<brief_summary>The purpose study understand bazedoxifene absorb body give combination 2 different formulation conjugate estrogen . It open label study placebo control comparator drug . Subjects take one dose investigation formulation daily 14 day .</brief_summary>
	<brief_title>Study Of Pharmacokinetic ( PK ) Profile Bazedoxifene ( BZA ) 2 BZA/Conjugated Estrogen Forms</brief_title>
	<detailed_description />
	<mesh_term>Estrogens , Conjugated ( USP )</mesh_term>
	<mesh_term>Estrogens</mesh_term>
	<mesh_term>Bazedoxifene</mesh_term>
	<criteria>Postmenopausal woman , age 40 65 year . Use oral estrogen , progestin , androgen , SERMcontaining drug product within 8 week screen . A history active presence clinically relevant important medical disease .</criteria>
	<gender>Female</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>December 2007</verification_date>
	<keyword>Postmenopause</keyword>
</DOC>